Advertisement
-- Total membership stood at 3 million at the end of June, 37.0% up on thesame period last year and 6.6% higher than the previous quarter.
-- Adjusted Operating Revenues totaled R$ 1,091.6 million in 2Q08, 32.1%more than in 2Q07. First-half net operating revenues came toR$ 2,089.0 million, 30.7% higher than in 1H07.
Advertisement
-- Adjusted EBITDA came to R$ 105.5 million in 2Q08 (a margin of 9.7%) andR$ 227.3 million (a margin of 10.9%) in 1H08, 16.7% and 21.5% up year-on-year,respectively.
-- The Medical Loss Ratio for membership utilization recorded 67.9% in2Q08 and 66.8% year-to-date. These ratios include additional costs related tothe dengue fever outbreak, totaling R$ 5.0 million, or 0.5 p.p., in the secondquarter, and R$ 9.0 million, or 0.4 p.p., in the first half.
-- The Company posted an Adjusted Net Income of R$ 79.0 million in 2Q08, a55.8% year-on-year improvement, and R$ 168.6 million in 1H08, 49.7% higherthan the same period last year.
To access the full version of the earnings release, visit our website athttp://www.amilpar.com.br/ir
About AmilPar
Amil Participacoes S.A. (Bovespa: AMIL3) is the largest MCO (managed careorganization) in Brazil, serving more than 3.0 million members in the statesof Sao Paulo, Rio de Janeiro, Parana and Distrito Federal. The Company is alsothe MCO with the largest accredited provider network in Brazil, with more than2,100 hospitals, 32,000 health care clinics and private practices and 5,900laboratories and diagnostic imaging centers.2nd Quarter 2008 Highlights
SOURCE AmilPar
